Search by Name

ID

180

Basic

Normal Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® IA-3 ( 4.6 x 150 mm 3 µm )

n-hexane / dichloromethane / ethanol / ethanolamine = 50 / 50 / 2 / 0.1

ID

285

Basic

Normal Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® IC ( 4.6 x 250 mm 5 µm )

n-heptane / ethanol / diethylamine = 85 / 15 / 0.1

ID

286

Basic

Normal Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® IC ( 4.6 x 250 mm 5 µm )

n-hexane / ethyl acetate / ethanolamine = 60 / 40 / 0.1

ID

287

Basic

Normal Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® IC ( 4.6 x 250 mm 5 µm )

n-hexane / tetrahydrofuran / diethylamine = 85 / 15 / 0.1

ID

624

Basic

Normal Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALCEL^® OD-H ( 4.6 x 250 mm 5 µm )

n-heptane / ethanol / diethylamine = 70 / 30 / 0.1

ID

717

Basic

Reverse Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® IA-3 ( 4.6 x 50 mm 3 µm )

20mM NH4CO3 aq. pH9.0 / acetonitrile = 70 / 30

ID

769

Basic

Reverse Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® AD-3R ( 4.6 x 50 mm 3 µm )

20mM NH4CO3 aq. pH9.0 / acetonitrile = 60 / 40

ID

814

Basic

Reverse Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALCEL^® OJ-RH ( 4.6 x 150 mm 5 µm )

20mM borate buffer pH9.0 / acetonitrile = 60 / 40

ID

964

Basic

Polar Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® IA-3 ( 4.6 x 150 mm 3 µm )

acetonitrile / ethanolamine = 100 / 0.1

ID

989

Basic

Polar Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® AY-3 ( 4.6 x 150 mm 3 µm )

ethanol / diethylamine = 100 / 0.1

ID

1052

Basic

Polar Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALCEL^® OJ-3 ( 4.6 x 150 mm 3 µm )

ethanol / diethylamine = 100 / 0.1

ID

1107

Basic

Polar Phase

9,10-Dihydro-2-methyl-4H-benzo-[5,6] cyclohept[1,2-d]oxazol-4-ol

CHIRALPAK^® AD-H ( 4.6 x 250 mm 5 µm )

acetonitrile = 100

ID

867

Basic

Reverse Phase

Acebutolol

CHIRALPAK^® CBH ( 4 x 100 mm 5 µm )

10mM NH4OAc aq. pH5.0 / 2-propanol = 95 / 5

ID

2285

Basic

Normal Phase

Acebutolol

CHIRALPAK^® IK ( 4.6 x 250 mm 5 µm )

n-hexane / 2-propanol / diethylamine = 60 / 40 / 0.1

ID

1489

Basic

Normal Phase

Afatinib

CHIRALPAK^® IE ( 4.6 x 250 mm 5 µm )

methanol / methyl tert-butyl ether / diethylamine = 80 / 20 / 0.1

ID

1656

Basic

Normal Phase

Afatinib

CHIRALPAK^® IE ( 4.6 x 250 mm 5 µm )

methyl tert-butyl ether / methanol / diethylamine = 20 / 80 / 0.1

ID

1340

Basic

Normal Phase

Afloqualone

CHIRALPAK^® IE ( 4.6 x 250 mm 5 µm )

n-hexane / ethanol / diethylamine = 80 / 20 / 0.1

ID

868

Basic

Reverse Phase

Alimemazine

CHIRALPAK^® AGP ( 4 x 100 mm 5 µm )

10mM NH4OAc aq. pH4.5 / acetonitrile = 95 / 5

ID

2292

Basic

Normal Phase

Alimemazine

CHIRALPAK^® IK-3 ( 4.6 x 250 mm 3 µm )

n-hexane / 2-propanol / diethylamine = 98 / 2 / 0.1

ID

1490

Basic

Normal Phase

Aliskiren

CHIRALPAK^® IE-3 ( 4.6 x 250 mm 3 µm )

methyl tert-butyl ether / acetonitrile / 1,4-dioxane / ethylenediamine = 80 / 20 / 1 / 0.05